{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:26:35Z","timestamp":1781000795886,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGY24H180003"],"award-info":[{"award-number":["LTGY24H180003"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.acra.2024.08.017","type":"journal-article","created":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:50:25Z","timestamp":1724460625000},"page":"526-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Thoracic Sarcopenia was a Poor Prognostic Predictor in Patients Receiving Immunotherapy for Advanced Non-small-cell Lung Cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Minhong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.acra.2024.08.017_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.acra.2024.08.017_bib2","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.acra.2024.08.017_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to anti-PD-monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/j.acra.2024.08.017_bib4","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.3390\/cancers13246355","article-title":"Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (NCSCL) treated with immune checkpoint inhibitors (ICIs): a prospective study","volume":"13","author":"Tenuta","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.acra.2024.08.017_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.18.00149","article-title":"Updated analysis of KEYNOTE-024: pembrolizumab versus platinum-based chemotherapy for advanced non-small-cell lung cancer With PD-L1 tumor proportion score of 50% or greater","volume":"37","author":"Reck","year":"2019","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.acra.2024.08.017_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdz109","article-title":"How to make the best use of immunotherapy as first-line treatment of advanced\/metastatic non-small-cell lung cancer","volume":"30","author":"Peters","year":"2019","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.acra.2024.08.017_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/jcsm.12755","article-title":"Predictive impact of sarcopenia in solid cancers treated with immune checkpoint inhibitors: a meta-analysis","volume":"12","author":"Takenaka","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.acra.2024.08.017_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cam4.3631","article-title":"Unfavorable impact of decreased muscle quality on the efficacy of immunotherapy for advanced non-small cell lung cancer","volume":"10","author":"Nishioka","year":"2021","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.acra.2024.08.017_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s41999-019-00233-w","article-title":"Sarcopenia and health-related outcomes: an umbrella review of observational studies","volume":"10","author":"Veronese","year":"2019","journal-title":"Eur Geriatr Med"},{"issue":"6","key":"10.1016\/j.acra.2024.08.017_bib10","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.21037\/jtd.2019.05.55","article-title":"Effects of preoperative sarcopenia on postoperative complications of minimally invasive oesophagectomy for oesophageal squamous cell carcinoma","volume":"11","author":"Xu","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.acra.2024.08.017_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106907","article-title":"Sarcopenia affects clinical efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients: a systematic review and meta-analysis","volume":"88","author":"Wang","year":"2020","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.acra.2024.08.017_bib12","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/jcsm.12305","article-title":"The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS)","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"9","key":"10.1016\/j.acra.2024.08.017_bib13","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/annonc\/mdx271","article-title":"Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy","volume":"28","author":"Bozzetti","year":"2017","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.acra.2024.08.017_bib14","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/fon-2017-0499","article-title":"Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?","volume":"14","author":"Rossi","year":"2018","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.acra.2024.08.017_bib15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00330-022-08980-4","article-title":"Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma","volume":"33","author":"Chen","year":"2023","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.acra.2024.08.017_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.chest.2019.04.115","article-title":"Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis","volume":"156","author":"Yang","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.acra.2024.08.017_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.arr.2016.03.006","article-title":"Regenerative function of immune system: modulation of muscle stem cells","volume":"27","author":"Saini","year":"2016","journal-title":"Ageing Res Rev"},{"issue":"9","key":"10.1016\/j.acra.2024.08.017_bib18","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.clon.2017.06.005","article-title":"Prediction of 90 day and overall survival after chemoradiotherapy for lung cancer: role of performance status and body composition","volume":"29","author":"Bowden","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"10.1016\/j.acra.2024.08.017_bib19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/s41430-018-0325-5","article-title":"A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer","volume":"73","author":"Gr\u00f8nberg","year":"2019","journal-title":"Eur J Clin Nutr"},{"issue":"11","key":"10.1016\/j.acra.2024.08.017_bib20","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.21037\/jtd-22-273","article-title":"The association between thoracic sarcopenia and survival is gender specific in early-stage lung cancer","volume":"14","author":"Wakefield","year":"2022","journal-title":"J Thorac Dis"},{"issue":"5","key":"10.1016\/j.acra.2024.08.017_bib21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.athoracsur.2018.01.013","article-title":"Thoracic skeletal muscle is associated with adverse outcomes after lobectomy for lung cancer","volume":"105","author":"Fintelmann","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.acra.2024.08.017_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/icvts\/ivy280","article-title":"Preoperative thoracic muscle area on computed tomography predicts long-term survival following pneumonectomy for lung cancer","volume":"28","author":"Troschel","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5","key":"10.1016\/j.acra.2024.08.017_bib23","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ejso.2018.09.026","article-title":"Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis","volume":"45","author":"Deng","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.acra.2024.08.017_bib24","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/cancers11070944","article-title":"Systematic review and meta-analysis of randomized, controlled trials on preoperative physical exercise interventions in patients with non-small-cell lung cancer","volume":"11","author":"Rosero","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.acra.2024.08.017_bib25","doi-asserted-by":"crossref","first-page":"e555","DOI":"10.1634\/theoncologist.2019-0463","article-title":"Physical activity and exercise in lung cancer care: will promises be fulfilled?","volume":"25","author":"Avancini","year":"2020","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.acra.2024.08.017_bib26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3390\/nu13041196","article-title":"The clinical value of nutritional care before and during active cancer treatment","volume":"13","author":"Aprile","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.acra.2024.08.017_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/01635581.2022.2153879","article-title":"Sarcopenia as a determinant of the efficacy of immune checkpoint inhibitors in non-small cell lung cancer: a meta-analysis","volume":"75","author":"Ren","year":"2023","journal-title":"Nutr Cancer"},{"issue":"4","key":"10.1016\/j.acra.2024.08.017_bib28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224005804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633224005804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:14:26Z","timestamp":1778588066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633224005804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1076633224005804"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2024.08.017","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thoracic Sarcopenia was a Poor Prognostic Predictor in Patients Receiving Immunotherapy for Advanced Non-small-cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2024.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Association of Academic Radiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}